IBDEI0VA ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15199,0)
 ;;=274.03^^81^940^32
 ;;^UTILITY(U,$J,358.3,15199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15199,1,4,0)
 ;;=4^274.03
 ;;^UTILITY(U,$J,358.3,15199,1,5,0)
 ;;=5^Gouty Arthritis, Chr w/ Tophi
 ;;^UTILITY(U,$J,358.3,15199,2)
 ;;=^338228
 ;;^UTILITY(U,$J,358.3,15200,0)
 ;;=729.90^^81^940^65
 ;;^UTILITY(U,$J,358.3,15200,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15200,1,4,0)
 ;;=4^729.90
 ;;^UTILITY(U,$J,358.3,15200,1,5,0)
 ;;=5^Soft Tissue Disorder
 ;;^UTILITY(U,$J,358.3,15200,2)
 ;;=^336762
 ;;^UTILITY(U,$J,358.3,15201,0)
 ;;=729.91^^81^940^57
 ;;^UTILITY(U,$J,358.3,15201,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15201,1,4,0)
 ;;=4^729.91
 ;;^UTILITY(U,$J,358.3,15201,1,5,0)
 ;;=5^Post-Traumatic Seroma
 ;;^UTILITY(U,$J,358.3,15201,2)
 ;;=^336654
 ;;^UTILITY(U,$J,358.3,15202,0)
 ;;=729.92^^81^940^38
 ;;^UTILITY(U,$J,358.3,15202,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15202,1,4,0)
 ;;=4^729.92
 ;;^UTILITY(U,$J,358.3,15202,1,5,0)
 ;;=5^Non-Traumatic Hematoma Soft Tissue
 ;;^UTILITY(U,$J,358.3,15202,2)
 ;;=^336655
 ;;^UTILITY(U,$J,358.3,15203,0)
 ;;=729.99^^81^940^66
 ;;^UTILITY(U,$J,358.3,15203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15203,1,4,0)
 ;;=4^729.99
 ;;^UTILITY(U,$J,358.3,15203,1,5,0)
 ;;=5^Soft Tissue Disorder NEC
 ;;^UTILITY(U,$J,358.3,15203,2)
 ;;=^336656
 ;;^UTILITY(U,$J,358.3,15204,0)
 ;;=781.0^^81^941^108
 ;;^UTILITY(U,$J,358.3,15204,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15204,1,4,0)
 ;;=4^781.0
 ;;^UTILITY(U,$J,358.3,15204,1,5,0)
 ;;=5^Tremor
 ;;^UTILITY(U,$J,358.3,15204,2)
 ;;=^23827
 ;;^UTILITY(U,$J,358.3,15205,0)
 ;;=351.0^^81^941^1
 ;;^UTILITY(U,$J,358.3,15205,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15205,1,4,0)
 ;;=4^351.0
 ;;^UTILITY(U,$J,358.3,15205,1,5,0)
 ;;=5^Bell's Palsy
 ;;^UTILITY(U,$J,358.3,15205,2)
 ;;=Bell's Palsy^13238
 ;;^UTILITY(U,$J,358.3,15206,0)
 ;;=386.11^^81^941^111
 ;;^UTILITY(U,$J,358.3,15206,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15206,1,4,0)
 ;;=4^386.11
 ;;^UTILITY(U,$J,358.3,15206,1,5,0)
 ;;=5^Vertigo, Benign Positional
 ;;^UTILITY(U,$J,358.3,15206,2)
 ;;=^269480
 ;;^UTILITY(U,$J,358.3,15207,0)
 ;;=784.0^^81^941^39
 ;;^UTILITY(U,$J,358.3,15207,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15207,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,15207,1,5,0)
 ;;=5^Headache
 ;;^UTILITY(U,$J,358.3,15207,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,15208,0)
 ;;=346.20^^81^941^44
 ;;^UTILITY(U,$J,358.3,15208,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15208,1,4,0)
 ;;=4^346.20
 ;;^UTILITY(U,$J,358.3,15208,1,5,0)
 ;;=5^Headache,Cluster/Migraine Variant
 ;;^UTILITY(U,$J,358.3,15208,2)
 ;;=^294062
 ;;^UTILITY(U,$J,358.3,15209,0)
 ;;=346.21^^81^941^45
 ;;^UTILITY(U,$J,358.3,15209,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15209,1,4,0)
 ;;=4^346.21
 ;;^UTILITY(U,$J,358.3,15209,1,5,0)
 ;;=5^Headache,Cluster/Migraine Variant Med Resistant
 ;;^UTILITY(U,$J,358.3,15209,2)
 ;;=^293879
 ;;^UTILITY(U,$J,358.3,15210,0)
 ;;=346.90^^81^941^76
 ;;^UTILITY(U,$J,358.3,15210,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15210,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,15210,1,5,0)
 ;;=5^Migraine Headache
 ;;^UTILITY(U,$J,358.3,15210,2)
 ;;=^293880
 ;;^UTILITY(U,$J,358.3,15211,0)
 ;;=346.91^^81^941^82
 ;;^UTILITY(U,$J,358.3,15211,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15211,1,4,0)
 ;;=4^346.91
 ;;^UTILITY(U,$J,358.3,15211,1,5,0)
 ;;=5^Migraines Resistant to Meds
 ;;^UTILITY(U,$J,358.3,15211,2)
 ;;=^293881
 ;;^UTILITY(U,$J,358.3,15212,0)
 ;;=307.81^^81^941^59
 ;;^UTILITY(U,$J,358.3,15212,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15212,1,4,0)
 ;;=4^307.81
 ;;
 ;;$END ROU IBDEI0VA
